Sign in

CIK 0001815442

  • Large accelerated filer

Kymera Therapeutics, Inc.

Sign in to watch
Ticker
KYMR
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
812992166
Phone
+1 857-285-5314
Business address
500 NORTH BEACON STREET, 4TH FLOOR, WATERTOWN, MA, 02472
Former names
Kymera Therapeutics, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$4,158,214
in 2 filings, $3.4M under 10b5-1 plans

Net −$4,158,214. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 68 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2021-12-16 Mainolfi Nello Chief Executive Officer Exercise or conversion · Stock Option (Right to Buy) −8,000 76,424
2021-12-03 Jacobs Bruce N. Chief Financial Officer Exercise or conversion +10,000 $2.08 $21K 27,514
2021-12-03 Jacobs Bruce N. Chief Financial Officer Sale −7,713 $53.31 $411K 19,801
2021-12-03 Jacobs Bruce N. Chief Financial Officer Sale −1,987 $54.32 $108K 17,814
2021-12-03 Jacobs Bruce N. Chief Financial Officer Sale −300 $55.07 $17K 17,514
2021-12-03 Jacobs Bruce N. Chief Financial Officer Exercise or conversion · Stock Option (Right to Buy) −10,000 189,899
2021-11-23 Jacobs Bruce N. Chief Financial Officer Exercise or conversion +10,000 $2.08 $21K 17,256
2021-11-23 Jacobs Bruce N. Chief Financial Officer Exercise or conversion · Stock Option (Right to Buy) −10,000 199,899
2021-06-16 Ridloff Elena Director Grant or award · Stock Option (Right to Buy) +10,459 10,459
2021-03-12 Ridloff Elena Director Grant or award · Stock Option (Right to Buy) +20,919 20,919

Page 41 of 41 · 810 trades